DYN Earnings

Quarterly EPS
$-0.96
Q3 2024
$-0.88
Q4 2024
$-1.05
Q1 2025
$-0.97
Q2 2025
$-0.76
Q3 2025
$-0.76
Q4 2025
$-0.73
Q1 2026
$-1.08
Q2 2026
Latest RevenueN/A
Latest Net Income-178556000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$1.080-178556000-11.3%
Q1 2026-$0.730-120854000+30.5%
Q4 2025-$0.760-111955000+13.6%
Q3 2025-$0.760-108041000+20.8%
Q2 2025-$0.970-110857000-38.6%
Q1 2025-$1.050-115361000-29.6%
Q4 2024-$0.880-89542000+18.5%
Q3 2024-$0.960-97125000+3.0%
Q2 2024-$0.700-65102000
Q1 2024-$0.810-65649000
Q4 2023-$1.080-66638000
Q3 2023-$0.990-60210000
Dyne Therapeutics (DYN) — Earnings